Sourasky Medical Center (Ichilov)
| Izrael | Turcja | Austria | |
| Chemioterapia przy guzie mózgu | - | od $1,000 | od $12,000 |
Państwo nie płacą za usługi Bookimed. Ceny na chemioterapię przy guzie mózgu na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu chemioterapii przy guzie mózgu. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Chemioterapia przy guzie mózgu.
Day 1: Arrival
Day 2-3: Pre-operation
Day 4-5: Chemotherapy for Brain Tumor
Day 6: Post-operation
Week 1-2: Rehabilitation
Week 3: Return to Normal Activities
Week 4: Final Result
Please note that the timeline and process can vary depending on individual circumstances and the specifics of the brain tumor. Always consult with your healthcare team for advice tailored to your situation.
Bookimed.com is a leading global medical tourism platform that offers a huge responsibility towards its clients, including patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
Bookimed provides an opportunity for patients to find the best medical solutions for Chemotherapy for Brain Tumor in Israel from top medical service providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed
Dyrektor Służby Neuroonkologii w Centrum Medycznym Sourasky’ego – dr Blumental wnosi wieloletnie specjalistyczne doświadczenie w dziedzinie chemioterapii guzów mózgu.
Kierownik Kliniki Neuroonkologii w Ichilow – dr Bokstein kieruje wyspecjalizowanym zespołem zajmującym się leczeniem guzów mózgu.
Profesor Shlomi Constantini specjalizuje się w opiece neurochirurgicznej nad pacjentami z guzami mózgu, posiadając zaawansowane szkolenie w zakresie neuroendoskopii i mikrochirurgii neurologicznej zdobyte w Europie.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Chemotherapy in Israel serves as a core component of multidisciplinary protocols for malignant brain tumors like glioblastoma and medulloblastoma. Israeli centers integrate pharmacological agents with molecular-genetic profiling, radiation, and innovative technologies to target high-grade tumors while minimizing the impact on the blood-brain barrier.
Bookimed Expert Insight: Israeli neuro-oncology emphasizes a limited but high-intensity chemotherapy window. Data suggests that extending treatment beyond 6 months offers no additional benefit, leading clinics like Sourasky Medical Center to prioritize early aggressive intervention combined with precision surgery where they maintain a 98% success rate.
Patient Consensus: Patients often choose Israel to access specialized clinical trials and advanced immunotherapy when standard treatments fail elsewhere. Many find that the focus on innovative, trial-stage therapies provides a vital roadmap for addressing recurring or high-grade tumors.
Brain tumor chemotherapy side effects typically include fatigue, nausea, hair loss, and suppressed blood cell counts. Patients commonly experience digestive issues, memory lapses known as chemo brain, and neuropathy. Long-term effects can include chronic exhaustion, bone density loss, and persistent cognitive challenges lasting years.
Bookimed Expert Insight: While patients focus on chemotherapy risks, supportive drugs often cause the most disruption. Data shows steroid treatments like Dexamethasone frequently trigger irritability and insomnia. Specialists at Sourasky Medical Center manage these interactions to improve quality of life during heavy cycles.
Patient Consensus: Fatigue is often the most debilitating reality, appearing increasingly heavy with each treatment cycle. Many find that managing constipation proactively is essential since anti-nausea medications often cause significant digestive slowdown.
Israel treats brain tumors using advanced systemic chemotherapy and targeted therapies tailored to the tumor's genetic profile. Specialists like Dr. Felix Bokstein at Sourasky Medical Center (Ichilov) utilize oral agents like temozolomide for glioblastoma, local carmustine implants during surgery, and molecular-driven protocols to penetrate the blood-brain barrier effectively.
Bookimed Expert Insight: Israeli oncology centers like Sourasky (Ichilov) prioritize Foundation One CDx genetic testing before starting chemotherapy. This allows doctors to bypass standard protocols for targeted drugs that specifically match the tumor's DNA. This precision approach often explains why their oncology success rates reach 90% in specialized departments.
Patient Consensus: Many patients find the Stupp protocol manageable but often discuss skipping vincristine in the PCV regimen to avoid nerve toxicity. Those with rare midline gliomas frequently seek clinical trials for specialized drugs like ONC201 rather than traditional chemotherapy.
Israeli clinics administer chemotherapy through intravenous infusions, oral medications, and localized techniques like Gliadel wafers or intrathecal delivery. Specialized oncology units at Sourasky Medical Center and Assuta use multidisciplinary protocols for drug delivery. These centers often include genetic testing to determine the most effective drug regimens.
Bookimed Expert Insight: Israeli oncology centers like Sourasky analyze tumor genetics through Foundation One CDx before starting chemotherapy. This data-driven approach helps doctors select specific drugs that bypass the blood-brain barrier effectively for each patient. It significantly improves response rates compared to standard protocols.
Patient Consensus: Patients often take oral chemotherapy capsules at night to reduce nausea. They frequently recommend using prescribed anti-nausea medications and supplements to manage side effects like constipation during treatment.
The medicated wafer treatment, clinically known as Gliadel (GliWafers), is a targeted brain tumor therapy used during neurosurgery in Israeli hospitals. Surgeons implant these biodegradable polymers directly into the cavity after tumor resection to release carmustine chemotherapy, targeting microscopic cancer cells while reducing systemic side effects.
Bookimed Expert Insight: While many think of this as a standalone cure, the most successful protocols at Sourasky Medical Center combine these wafers with Novalis TrueBeam STx radiation. Dr. Felix Bokstein oversees this integration, ensuring the localized chemotherapy works alongside precision radiotherapy to maximize life expectancy in aggressive cases.
Patient Consensus: Patients emphasize discussing chemo wafers during the initial surgical consultation rather than after the procedure. They report a preference for localized delivery to minimize the heavy fatigue often associated with systemic drugs.
Israel is a global hub for advanced targeted therapies, offering cutting-edge treatments like Alpha DaRT, TIL therapy, and IDH-mutant targeted drugs. Major centers such as Sourasky Medical Center provide personalized protocols including Foundation One CDx genetic testing to identify precise molecular markers for brain tumors.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center manage high volumes of over 40,000 cancer patients annually. This massive scale allows clinics to provide advanced genetic profiling faster than most international hospitals. Patients gain rapid access to newly approved drugs and targeted therapies like IDH-mutant treatments before they reach widespread global availability.
Patient Consensus: Patients value Israel as a pioneer for specialized treatments like Alpha DaRT for glioblastoma. Many recommend contacting major Tel Aviv centers early to confirm eligibility for experimental vaccines or clinical trials.
Major Israeli hospitals offer specialized clinical trials for brain tumors, focusing on advanced immunotherapies, gene editing, and cellular research. Centers like Sourasky Medical Center and Sheba Medical Center provide trial access for pediatric and adult cases, including innovative protocols for recurrent glioblastoma and medulloblastoma.
Bookimed Expert Insight: While chemotherapy for brain tumors averages $2,400 to $5,500 in Israel, participation in an access study like Alpha DaRT at Hadassah can provide unique pathways for patients with recurrent tumors. Senior neuro-oncologists, such as Dr. Dvora Blumental who trained at Memorial Sloan-Kettering, lead these trials, ensuring American-standard oversight within Israels high-volume oncology departments.
Patient Consensus: Patients emphasize the need to verify eligibility via clinicaltrials.gov or hospital international offices since access studies have very strict enrollment criteria. Many find that experimental options like DC vaccines offer hope when standard chemotherapy protocols have been exhausted.